Clinical Trials Logo

Lung Diseases, Obstructive clinical trials

View clinical trials related to Lung Diseases, Obstructive.

Filter by:

NCT ID: NCT02798003 Recruiting - Clinical trials for Non-small Cell Lung Cancer

Food Reward in Cachexia Induced by Acute or Chronic Disease

Start date: November 2016
Phase: N/A
Study type: Observational

To study activity in the reward-circuitry of the brain in patients suffering from cachexia induced by cancer or chronic disease.

NCT ID: NCT02790047 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD

HBEcPEP
Start date: October 2016
Phase: N/A
Study type: Interventional

The aim of this study to investigate the efficacy of a home-base exercise program with a new conical PEP device on physical performance and health related quality of life in COPD patients.

NCT ID: NCT02786030 Recruiting - Asthma Clinical Trials

Integrated Primary Care for Chronic Lung Disease: PACK Brazil

PACKBrazilR
Start date: April 1, 2017
Phase: N/A
Study type: Interventional

This study will evaluate a complex intervention based on a patient management tool (PMT), combined with educational outreach to primary care doctors, nurses and other health workers, in the Brazilian city of Florianopolis. The intervention is aimed at improving the quality of respiratory care and respiratory health outcomes, and comorbid conditions, in adults with asthma and chronic obstructive pulmonary disease (COPD). The effectiveness of the intervention will be assessed by randomly allocating 48 primary care clinics to receive the intervention or not, and comparing patient and clinic level endpoints that reflect the health and quality of care provided over the following year. About 1250 patients known to have been diagnosed with asthma and 700 with COPD in participating clinics and will be included in the study. The primary endpoints for patients with asthma and COPD, respectively, will be composite scores indicating appropriate prescribing and diagnostic testing. The third primary endpoint, among all adult clinic users, will be rates of new diagnoses of asthma and COPD in each clinic. Secondary endpoints will include the individual components of the composite scores, health measures (hospital admissions and deaths), and indicators of appropriate management of comorbid conditions such as cardiovascular risk factors. Eligible patients will be identified and outcomes measured using electronic medical records.

NCT ID: NCT02778802 Recruiting - Clinical trials for Pulmonary Hypertension

Pulmonary Hemodynamics in Patients With Severe Emphysema Pre and Post BLVR

Start date: June 2016
Phase: N/A
Study type: Observational

This study is designed as a prospective study, with the primary endpoint being changes in pulmonary hemodynamic parameters after ELVR in patients with severe emphysema. Secondary endpoints will be changes in lung function parameters, exercise capacity, and QoL.

NCT ID: NCT02770677 Recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

Modified Dantien Salee Yoga Training Program in Chronic Obstructive Pulmonary Disease Rehabilitation

Start date: April 7, 2016
Phase: N/A
Study type: Interventional

COPD patients will be recruited and assigned into one of each group: 1) Control group or 2) Yoga group. In Yoga groups, subjected will be asked to participate in Modified Dantien Yoga training for 12 weeks (3 times/week, 60 min/time). The subjects will be evaluated their pulmonary function, functional fitness performance, dyspnea score, and quality of life at baseline and after 12 wk training.

NCT ID: NCT02755363 Recruiting - COPD Clinical Trials

Effects of Osteopathic Techniques on Residual Volume in Severe Chronic Obstructive Pulmonary Disease

Start date: April 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the selected osteopathic techniques have a positive impact on the residual volume decrease in patients with chronic obstructive pulmonary disease with severe and very severe airflow limitation in comparison to the manual therapy not aimed to decrease hyperinflation (placebo).

NCT ID: NCT02748798 Recruiting - Asthma Clinical Trials

Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders

Start date: November 10, 2020
Phase: Early Phase 1
Study type: Interventional

The goal of this research is to optimize the MRI system to obtain ideal lung images using Hyperpolarized (HP) Noble and Inert Fluorinated Gases as contrast agents. Lung coils tuned to the frequencies of these gases will be used. This study will take place at TBRHSC in the Cardiorespiratory Department and in the Research MRI facility.

NCT ID: NCT02719457 Recruiting - Clinical trials for Pulmonary Disease, Chronic Obstructive

Spot Marching Exercise Test in Chronic Obstructive Pulmonary Disease

SMT
Start date: April 2016
Phase: N/A
Study type: Interventional

the aim of this study to assess the relationship and compare physiological response between spot marching exercise test and 6 minute walk test in patient with chronic obstructive pulmonary disease

NCT ID: NCT02659189 Recruiting - Death Clinical Trials

Hospitalary Chronic Obstructive Pulmonary Disease Registry

Start date: July 2016
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to create an institutional registry of Chronic Obstructive Pulmonary disease through a prospective survey based on epidemiological data, risk factors, diagnosis, prognosis, treatment, monitoring and survival.

NCT ID: NCT02645305 Recruiting - COPD Clinical Trials

Adipose Derived Stem Cells Transplantation for Chronic Obstructive Pulmonary Disease

Start date: June 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is the name for a collection of lung diseases including chronic bronchitis, emphysema and chronic obstructive airways disease. People with COPD have difficulties breathing, primarily due to the narrowing of their airways, this is called airflow obstruction. Some preclinical evaluations showed that COPD is closely related to chronic inflammation; therefore, this study aimed to use adipose-derived stem cells (ADSCs) in the form of non-expanded culture - that usually names as a stromal vascular fraction (SVF) in combination with activated platelet rich plasma (PRP) to treat this disease. Both SVF and PRP are autologous sources that obtained from adipose tissue and peripheral blood, respectively. This mixture is intravenously transfused into the patients.